New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
14:57 EDTDNDNDendreon breaks out, fills prior bearish gap, levels to watch
Shares are up over 10% at time of writing, pushing well above the 10-day moving average. While the prior bearish gap from the summer was filled more than two weeks ago, the recent decline called the bullishness of that move into question. At the current price of $7.12, next resistance is at $7.20, the pivot high before the gap happened. Support is at $6.89, a prior pivot in the recent trading range of the last few weeks.
News For DNDN From The Last 14 Days
Check below for free stories on DNDN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 11, 2014
07:01 EDTDNDNDendreon: Immune responses enhanced when Provenge given after ADT
Dendreon Corporation announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when PROVENGE is given after androgen deprivation therapy in patients with biochemically-recurrent prostate cancer at high risk for metastases. These data will be presented at the 29th Annual European Association of Urology Congress taking place from April 11-15, 2014 in Stockholm, Sweden.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use